Clinical Trial Update: Autologous Adipose-Derived Stromal Cell Delivered Via Intramuscular Injections for the Treatment of Critical Limb Ischemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating autologous adipose-derived stromal cells delivered by intramuscular injections for critical limb ischemia has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Autologous adipose-derived stromal cell therapy

Snippet

Sponsor: Ageless Regenerative Institute | Conditions: Critical Limb Ischemia | Phase 1 | Status: WITHDRAWN